FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014164772> ?p ?o ?g. }

• W2014164772 endingPage "79" @default.
• W2014164772 startingPage "73" @default.
• W2014164772 abstract "Background Aldosterone levels are high early after admission for ST elevation myocardial infarction (STEMI) concomitantly with high risk of sudden death and life-threatening ventricular arrhythmia. Methods We assessed the hypothesis that early aldosterone blockade on admission for primary percutaneous coronary intervention (PCI) may be associated with a reduction of life-threatening ventricular arrhythmia in a prospective cohort-nested case (n=159) versus historical control (n=623) study. All cases were treated on admission by 200 mg IV bolus of potassium canrenoate, followed by 25 mg PO spironolactone daily during the coronary care unit stay. The primary endpoint – in-hospital composite of death, resuscitated cardiac arrest and ventricular tachycardia – was assessed by logistic regression models adjusted on major pre-specified variables and validated by a bootstrap procedure and propensity-score based analyses. Results Aldosterone blockade was associated with lower risks of the primary endpoint (adjusted ORs 0.26, 95% CI [0.13–0.57]), resuscitated cardiac arrest (adjusted OR 0.39, 95% CI [0.16–0.94]), ventricular tachycardia or fibrillation (adjusted ORs 0.23, 95% CI [0.12–0.45]), as well as ventricular arrhythmia requiring resuscitation or anti-arrhythmic therapy (adjusted OR 0.41, 95% CI [0.19–0.88]). All findings were confirmed by the bootstrap procedure. The benefit on death or resuscitated cardiac arrest seemed sustained at 6 month follow-up. Conclusions Early aldosterone blockade in patients presenting for primary PCI for STEMI is associated with significant reductions in rates of life-threatening arrhythmia and cardiac arrest independent of the initial risk profile, heart failure or hemodynamic status. These findings support the concept of aldosterone blockade early after STEMI, warranting further confirmation by ongoing randomized trials." @default.
• W2014164772 created "2016-06-24" @default.
• W2014164772 creator A5001207429 @default.
• W2014164772 creator A5003014889 @default.
• W2014164772 creator A5009185933 @default.
• W2014164772 creator A5027244910 @default.
• W2014164772 creator A5032224302 @default.
• W2014164772 creator A5032245948 @default.
• W2014164772 creator A5035015657 @default.
• W2014164772 creator A5037423816 @default.
• W2014164772 creator A5043811212 @default.
• W2014164772 creator A5049810321 @default.
• W2014164772 creator A5061992582 @default.
• W2014164772 creator A5065537677 @default.
• W2014164772 date "2013-07-01" @default.
• W2014164772 modified "2023-10-18" @default.
• W2014164772 title "Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia" @default.
• W2014164772 cites W1963800342 @default.
• W2014164772 cites W1968355808 @default.
• W2014164772 cites W1969703985 @default.
• W2014164772 cites W1971595373 @default.
• W2014164772 cites W1972942274 @default.
• W2014164772 cites W1987045148 @default.
• W2014164772 cites W2000693095 @default.
• W2014164772 cites W2002374666 @default.
• W2014164772 cites W2016611490 @default.
• W2014164772 cites W2040312630 @default.
• W2014164772 cites W2043638707 @default.
• W2014164772 cites W2044113152 @default.
• W2014164772 cites W2044890547 @default.
• W2014164772 cites W2057886201 @default.
• W2014164772 cites W2080467497 @default.
• W2014164772 cites W2085311779 @default.
• W2014164772 cites W2088734363 @default.
• W2014164772 cites W2100503859 @default.
• W2014164772 cites W2100845096 @default.
• W2014164772 cites W2114159500 @default.
• W2014164772 cites W2119435620 @default.
• W2014164772 cites W2123021239 @default.
• W2014164772 cites W2125448511 @default.
• W2014164772 cites W2133434335 @default.
• W2014164772 cites W2143518969 @default.
• W2014164772 cites W2149081700 @default.
• W2014164772 cites W2152094259 @default.
• W2014164772 cites W2157184686 @default.
• W2014164772 cites W2159091854 @default.
• W2014164772 cites W2159571720 @default.
• W2014164772 cites W2164152578 @default.
• W2014164772 cites W2164705414 @default.
• W2014164772 cites W2166181017 @default.
• W2014164772 cites W2167010514 @default.
• W2014164772 cites W2168453807 @default.
• W2014164772 cites W2265814318 @default.
• W2014164772 cites W2323458614 @default.
• W2014164772 cites W2333638686 @default.
• W2014164772 cites W4242621865 @default.
• W2014164772 cites W4362208330 @default.
• W2014164772 cites W4378077933 @default.
• W2014164772 doi "https://doi.org/10.1016/j.ijcard.2011.11.076" @default.
• W2014164772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22200184" @default.
• W2014164772 hasPublicationYear "2013" @default.
• W2014164772 type Work @default.
• W2014164772 sameAs 2014164772 @default.
• W2014164772 citedByCount "27" @default.
• W2014164772 countsByYear W20141647722013 @default.
• W2014164772 countsByYear W20141647722014 @default.
• W2014164772 countsByYear W20141647722015 @default.
• W2014164772 countsByYear W20141647722016 @default.
• W2014164772 countsByYear W20141647722017 @default.
• W2014164772 countsByYear W20141647722018 @default.
• W2014164772 countsByYear W20141647722019 @default.
• W2014164772 countsByYear W20141647722020 @default.
• W2014164772 countsByYear W20141647722022 @default.
• W2014164772 crossrefType "journal-article" @default.
• W2014164772 hasAuthorship W2014164772A5001207429 @default.
• W2014164772 hasAuthorship W2014164772A5003014889 @default.
• W2014164772 hasAuthorship W2014164772A5009185933 @default.
• W2014164772 hasAuthorship W2014164772A5027244910 @default.
• W2014164772 hasAuthorship W2014164772A5032224302 @default.
• W2014164772 hasAuthorship W2014164772A5032245948 @default.
• W2014164772 hasAuthorship W2014164772A5035015657 @default.
• W2014164772 hasAuthorship W2014164772A5037423816 @default.
• W2014164772 hasAuthorship W2014164772A5043811212 @default.
• W2014164772 hasAuthorship W2014164772A5049810321 @default.
• W2014164772 hasAuthorship W2014164772A5061992582 @default.
• W2014164772 hasAuthorship W2014164772A5065537677 @default.
• W2014164772 hasConcept C126322002 @default.
• W2014164772 hasConcept C164705383 @default.
• W2014164772 hasConcept C168563851 @default.
• W2014164772 hasConcept C203092338 @default.
• W2014164772 hasConcept C2775935837 @default.
• W2014164772 hasConcept C2776331378 @default.
• W2014164772 hasConcept C2777055891 @default.
• W2014164772 hasConcept C2778165595 @default.
• W2014164772 hasConcept C2778525890 @default.
• W2014164772 hasConcept C2778619729 @default.
• W2014164772 hasConcept C2780400711 @default.
• W2014164772 hasConcept C2781005686 @default.

• next